DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Dentsply Sirona's positive outlook is supported by strong revenue growth across various segments, notably in Orthodontics where revenue surged by double digits, indicating robust consumer demand and market presence. The firm reported a 6.2% increase in net sales overall, demonstrating resilience in its broader product offerings, while specific segments like Wellspect Healthcare showed substantial revenue growth, solidifying its diverse portfolio. Additionally, the company's continued expansion in European markets, with reported sales growth of 9.9%, reinforces its competitive position and potential for sustained profitability in the global dental equipment and supplies sector.

Dentsply Sirona is projecting a decline in constant currency sales of -4% to -5%, a downward revision from an earlier forecast of -2% to -4%. The company anticipates a reduction of 160 basis points in GAAP gross margin for Q3/25 compared to the same period in 2024 and estimates a decline in adjusted EBITDA margins for FY/25, indicating concerns about profitability going forward. Furthermore, revenue from the connected technology solutions segment experienced a 3.9% decline, and challenges in the orthodontics and implants segment, particularly related to the Byte clear aligner, are expected to contribute to a significant revenue drop of 15%.